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Abstract
Background: We examined whether the effect of maternal smoking during pregnancy on
birthweight of the offspring was mediated by smoking-induced changes to DNA methyla-
tion in cord blood.
Methods: First, we used cord blood of 129 Dutch children exposed to maternal smoking
vs 126 unexposed to maternal and paternal smoking (53% male) participating in the
GECKO Drenthe birth cohort. DNA methylation was measured using the Illumina
HumanMethylation450 Beadchip. We performed an epigenome-wide association study
for the association between maternal smoking and methylation followed by a mediation
analysis of the top signals [false-discovery rate (FDR)< 0.05]. We adjusted both analyses
for maternal age, education, pre-pregnancy BMI, offspring’s sex, gestational age and
white blood cell composition. Secondly, in 175 exposed and 1248 unexposed newborns
from two independent birth cohorts, we replicated and meta-analysed results of eight
cytosine-phosphate-guanine (CpG) sites in the GFI1 gene, which showed the most robust
mediation. Finally, we performed functional network and enrichment analysis.
Results: We found 35 differentially methylated CpGs (FDR<0.05) in newborns exposed vs
unexposed to smoking, of which 23 survived Bonferroni correction (P< 110-7). These 23
CpGs mapped to eight genes: AHRR, GFI1, MYO1G, CYP1A1, NEUROG1, CNTNAP2,
FRMD4A and LRP5. We observed partial confirmation as three of the eight CpGs in GFI1 repli-
cated. These CpGs partly mediated the effect of maternal smoking on birthweight (Sobel
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P< 0.05) in meta-analysis of GECKO and the two replication cohorts. Differential methylation
of these three GFI1 CpGs explained 12–19% of the 202 g lower birthweight in smoking moth-
ers. Functional enrichment analysis pointed towards activation of cell-mediated immunity.
Conclusions: Maternal smoking during pregnancy was associated with cord blood
methylation differences. We observed a potentially mediating role of methylation in the
association between maternal smoking during pregnancy and birthweight of the off-
spring. Functional network analysis suggested a role in activating the immune system.
Key words: Epigenetic epidemiology, epigenome-wide association study, DOHaD, fetal programming, GECKO,
ALSPAC, Generation R
Introduction
It is well known that maternal smoking during pregnancy
can cause intrauterine growth restriction and low birth-
weight.1–4 Low birthweight, in turn, has been associated
with increased childhood growth and cardiometabolic
problems in childhood and adulthood.5,6 The development
of chronic diseases in adulthood is therefore believed to start
during pregnancy as a result of exposure to adverse intra-
uterine environments, also known as fetal programming.
We hypothesized that the long-lasting effects of adverse fetal
exposures (e.g. smoking) on birthweight and subsequent
cardiometabolic risk are at least partly caused by DNA
methylation.7–9 Thus, maternal smoking during pregnancy
may have adverse health consequences during the offspring’s
entire life course via DNA methylation.
In recent studies, tobacco smoke exposure has been asso-
ciated with DNA methylation changes in smokers.10–12 The
effect of maternal tobacco smoking during pregnancy on
DNA methylation of their offspring has also been
investigated in a number of studies using different de-
signs.13–20 Several of these studies in offspring investigated
global or gene-specific DNA methylation differences, in um-
bilical cord blood and placental cells.13,14,16,21 Several stud-
ies have used an epigenome-wide association study (EWAS)
design,17–20 focusing on methylation differences of individ-
ual cytosine-phosphate-guanine (CpG) sites. Some EWASs
used the 27 k chip (Illumina Inc., San Diego, USA) in placen-
tal samples or whole blood samples of children and identi-
fied methylation of several CpGs to be associated with
maternal smoking during pregnancy.19,20 Other EWASs
used the 450 K chip (Illumina Inc., San Diego, USA) to iden-
tify changes in methylation associated with maternal smok-
ing during pregnancy.17,18 Joubert et al.17 identified and
replicated methylation changes in cord blood of several
genes (AHRR, CYP1A1 and GFI1) associated with mater-
nal smoking during pregnancy. More recently, Markunas
et al.18 identified and replicated differential methylation of
CpGs in 10 novel genes in whole blood from 889 newborns.
Other EWASs studied associations with birthweight.22,23
Adkins et al.23 found no epigenome-wide associations with
birthweight, whereas Engel et al.22 identified 19 CpGs.
Interestingly, no studies investigated mediation by methyla-
tion in the association between maternal smoking and birth-
weight or other health-related outcomes.
Therefore, we conducted an EWAS in cord blood to
examine the association between maternal smoking during
pregnancy and DNA methylation, with the 450 K chip.
Furthermore, we studied for the first time whether differ-
entially methylated CpGs mediated the effect of smoking
on birthweight. Finally, we sought to replicate the most
promising mediation findings in two independent birth co-
horts, and meta-analysed the results.
Methods
Subjects
We derived data from GECKO Drenthe, a Dutch popula-
tion-based birth cohort that studies risk factors associated
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with the development of overweight from birth into adult-
hood.24 The cohort includes 2874 children born between
April 2006 and April 2007. Children have been extensively
phenotyped on parental characteristics, pregnancy and de-
livery, children’s health, nutrition and childhood growth.
Data were gathered during pregnancy and at multiple time
points during childhood. Maternal and paternal smoking
during pregnancy were self-reported and (if available)
additional information from obstetricians was used.
Directly after delivery, umbilical cord blood was collected
from 1565 children and stored at -80C. DNA was ex-
tracted from the buffy coats using the QIAamp96 DNA
Blood Kit (QIAGEN). To increase DNA concentration
to 50 ng/ml, all samples were treated with Glycoblue.
From all children in the total cohort with stored
cord blood, we selected those that had sufficient DNA
of good quality after DNA isolation (DNA concentra-
tion 50mg/ml). Of those, we excluded non-Dutch new-
borns, premature newborns (37 weeks), twins and those
with a mother with (gestational) diabetes. We also
excluded children with missing information on these vari-
ables, which resulted in n¼ 1118. Then 447 children were
selected because they had information on maternal and
paternal smoking during pregnancy and the number of
cigarettes smoked by the mother. This resulted in 129
children exposed to maternal smoking and 318 children
unexposed to either maternal or paternal smoking. This
group of 447 did not differ from the group of 1118 on ges-
tational age, birthweight, maternal educational level or
gender. Only the maternal pre-pregnancy BMI of the group
of 447 was slightly lower (24.4 vs 25.0 kg/m2). Therefore,
we concluded that these 447 were broadly representative
of the total cohort. We used the complete exposed group
(n¼ 129) and randomly selected 129 unexposed newborns
(of which 3 dropped out during QC), see flowchart in
Supplementary Figure S1, available as Supplementary data
at IJE online.
This study has been approved by the Medical Ethics
Committee of the University Medical Center Groningen,
and parents of all participants gave written informed
consent.
Genome-wide methylation assay
We used 500 ng DNA per sample to perform methylation
analysis. To minimize batch effects, we randomized all
samples on sex and exposure status per chip over three
96-well plates. Thus each chip contained three exposed
boys, three unexposed boys, three exposed girls and three
unexposed girls. In addition, we randomly assigned five
control samples of the same male to each plate; two on the
first plate, two on the second plate and one on the third
plate. We performed bisulphite conversion using the
EZ-96 DNA methylation kit (Zymo research Corporation,
Irvine, USA). After validating that unmethylated cyto-
sines had converted to thymidines using commercially
available bisulphite conversion controls (Zymo Research
Corporation, Irvine, USA), we processed the samples using
the Infinium HumanMethylation450 BeadChip (Illumina
Inc., San Diego, USA). We checked performance of built-in
internal quality controls in the Controls Dashboard in the
methylation module of GenomeStudio (Illumina Inc., San
Diego, USA).
Quality control
For all 485 577 CpGs we calculated beta-values and detec-
tion P-values using the Minfi R package.25 Overall, beta-
values ranged from zero to one, showing the level of
methylation for each CpG, and detection P-values<0.05
indicated that the target sequence signal was distinguish-
able from the background. We performed all quality con-
trol steps for the three plates separately. Cluster plots for
the betas on the X chromosome showed a clear distinction
by sex. Two males were in the female cluster, and were
excluded from further analyses. Illumina-suggested back-
ground normalization and colour correction were per-
formed. One sample did not meet the criterion of 99%
of the CpGs with detection P-value< 0.05 and was
excluded. This resulted in a final sample of 255 children:
129 exposed and 126 unexposed. Control probes, probes
on X or Y chromosomes and probes that did not meet our
criteria of a detection P-value of<0.05 in99% of the
samples were excluded. This resulted in 465 891 remaining
CpGs. The five duplicate male control samples (included in
each plate) showed high correlations ranging from 0.995
to 0.998, indicating that batch effects were minimal. These
five samples were removed from further analyses.
Statistical analyses
We performed all pre-processing steps using R packages
SWAN (Subset-quantile Within Array Normalization) and
Minfi25 and linear regression in the R package Limma
(Linear Models for Microarray Analysis).26 We generated
basic characteristics, mediation analysis and the volcano
plot in Stata v12 (StataCorp, College Station, TX, USA).
Epigenome-wide association (EWAS) analysis
We performed linear regression analyses in Limma com-
paring the methylation beta values of the exposed with the
unexposed group. We adjusted for the following covariates
that were selected based on their expected association with
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maternal smoking and/or methylation: sex, gestational age,
maternal age, pre-pregnancy BMI, educational level, plate
number and cell type composition.17,18,27 Sex and gesta-
tional age (weeks) were reported by obstetricians.
Maternal educational level (low/average vs university
educated), maternal BMI before pregnancy (kg/m2) and
maternal age (years) were self-reported by the mothers.
Missing values on gestational age (n¼ 2), maternal educa-
tional level (n¼3) and maternal pre-pregnancy BMI
(n¼ 8) were imputed with the mean/median to maintain
power. Excluding the 10 newborns with1 missing cova-
riate did not alter the results, and since multiple imputation
in an EWAS dataset would be computationally burden-
some, we present our findings including these 10 samples
with single imputed covariate data. Furthermore, the num-
ber of participants with missing data was very small, thus
substantial bias was unlikely. Additionally, we included
plate number to adjust for potential batch effects and we
calculated cell type proportions based on the method previ-
ously presented by Houseman and colleagues28 with the
dataset presented by Reinius and colleagues.29 These cell
type proportions (B cells, granulocytes, monocytes, NK
cells, CD4þ T cells and CD8þ T cells) were included as
covariates in the model. As a sensitivity analysis, we also
performed our analysis without correction for cell type and
even in a crude model without any of the covariates, to test
the effect of these covariates on our results. We converted
raw P-values to false discovery rates (FDRs) based on
Benjamini and Hochberg.30 We used both FDR<0.05
(raw P< 7.5 10-6) and Bonferroni corrected P-values
(raw P< 1 10-7) as significance thresholds. We tested a
dose-response effect of number of cigarettes per day on
methylation in the exposed group for those signals with
FDR< 0.05.
Mediation analysis
We tested the CpGs with FDR< 0.05 for mediation in the
association between maternal smoking during pregnancy
and birthweight, using the widely used method of Baron
and Kenny31 and the Sobel test.32 As shown in Figure 1,
mediation was considered to be present when: (i) smoking
correlated with methylation level (ba); (ii) smoking corre-
lated with birthweight without adjusting the model for the
mediator (bc); (iii) differential methylation correlated with
birthweight (bb); (iv) the association between smoking and
birthweight decreased upon addition of methylation to the
model (bc’); and (v) the Sobel test gave P< 0.05, indicating
a decrease in the effect of smoking on birthweight after ad-
justing for the differentially methylated CpG. For those
CpGs showing mediation, we tested the assumption that
there is no interaction of the exposure and covariates with
the mediator CpGs.33,34 For the mediating CpGs, we fur-
ther calculated which part of the association between
smoking and birthweight could be explained by the medi-
ator using the formula:35
b a b bð Þ= b a b bð Þþ b c0ð Þ:
The mediation effect ba*bb equals bc - bc’, thus this formula
equals:
b c b c0= b c:
Functional network analysis
We performed network and enrichment analysis to facili-
tate the functional interpretation of our differentially
methylated genes using GeneMANIA.36,37 To this end, we
selected all genes to which the top CpGs (FDR< 0.05)
mapped as input, to construct a functional interaction net-
work by adding the 100 most strongly interacting genes.
Data resources used by the GeneMANIA algorithm were
functional association datasets including genetic inter-
actions, protein-protein, co-expression, shared protein do-
mains and co-localization networks.36,38 Functional
enrichment analysis of all genes of the constructed inter-
action network against Gene Ontology (GO) terms was
performed to find the most enriched GO terms.
Replication
We performed replication analyses for the top findings of
our EWAS and mediation analysis in two independent
birth cohorts with 450 K methylation data in cord
blood samples from Caucasian children: ALSPAC
(Avon, UK)39,40 and Generation R (Rotterdam, The
Netherlands41). For the replication analyses, we analysed
data of 65 exposed and 613 unexposed offspring in
ALSPAC and 110 exposed and 635 unexposed offspring in
smoking
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Figure 1. Hypothetical mediation model explaining the variables
in the mediation analysis. ba, effect estimate for smoking in the model:
CpG¼ smokingþ covariates. bb, effect estimate for CpG in the model:
BW¼CpGþ covariates. bc, effect estimate for smoking in the
model: BW¼ smokingþ covariates. bc’: effect estimate for smoking in
the model: BW¼ smokingþCpGþ covariates.
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Generation R (see Supplementary text and Supplementary
Table S1, available as Supplementary data at IJE online).
All eight GFI1 CpGs with FDR<0.05 in the EWAS were
taken forward for replication. We limited replication to
the GFI1 gene as its CpGs showed the most robust and
clearest mediation results and GFI1 was among the genes
with the most robust EWAS signals in GECKO.
Furthermore, unlike NEUROG1, differential methylation
of GFI1 was previously reported to be associated with ma-
ternal smoking.17 Exposure in the replication cohorts was
defined as sustained maternal smoking during pregnancy
vs no maternal smoking during pregnancy, because this
was the most accurate measure of exposure in the replica-
tion cohorts. Paternal smoking was adjusted for in the me-
diation analysis. Except for this additional covariate,
mediation analyses were performed using the same analysis
protocol as in GECKO. In order to obtain one overall esti-
mate of the results for each of the eight GFI1 CpGs, we
used fixed effects inverse variance meta-analysis of the re-
sults of the two replication cohorts. Subsequently, we com-
bined results of discovery (GECKO) and replication
(ALSPAC and Generation R) stages in a joint meta-
analysis. We concluded that mediation was present for
CpGs showing a two-sided P< 0.05 in both the replication
and the joint meta-analysis.
Results
General characteristics of all participants in GECKO are
presented in Table 1, for characteristics of ALSPAC and
Generation R participants see Supplementary Table S1,
available as Supplementary data at IJE online. On average,
in GECKO, smoking mothers were 1.4 years younger and
more often had a lower educational level and their children
had a 281 g lower birthweight.
We found 35 CpGs, mapping to 10 genes, that showed
differential methylation (FDR< 0.05) between the groups
exposed and unexposed to maternal smoking (Table 2).
After the more conservative Bonferroni correction, 23
CpGs remained. These 23 CpGs mapped to eight
genes: AHRR, GFI1, MYO1G, CYP1A1, NEUROG1,
CNTNAP2, FRMD4A and LRP5. All eight CpGs mapping
to GFI1, LRP5 and CNTNAP2 had lower methylation
levels in the group exposed to maternal smoking during
pregnancy compared with the unexposed group (methyla-
tion difference (beta value exposed minus beta value unex-
posed) ranged from 0.021 to 0.117). The 11 CpGs that
mapped to MYO1G, NEUROG1, FRMD4A and CYP1A1
had higher methylation levels in the exposed group (methy-
lation difference ranged from 0.028 to 0.077). For AHRR,
three CpGs had lower methylation levels (methylation
difference between 0.024 and 0.073) whereas one had
higher methylation in the exposed group (methylation dif-
ference 0.038).
Effects of covariate adjustment on EWAS results
are shown in Supplementary Table S2, available as
Supplementary data at IJE online. Analysis without adjust-
ment for cell type distribution did not substantially change
our top (Bonferroni significant) findings, but the list of
CpGs with FDR< 0.05 decreased substantially after cell
type correction.
The volcano plot in Figure 2 shows the methylation dif-
ferences between the exposed and unexposed groups plot-
ted against statistical significance. It shows the 35
differentially methylated CpGs (FDR< 0.05) and the 23
CpGs that remained statistically significant after
Bonferroni correction.
We observed no dose-response effect of number of cig-
arettes smoked per day on differential methylation in the
exposed group for any of the 35 top CpGs (data not
shown).
Next, we considered the 35 top CpGs to test for the
mediating effect in the association between maternal smok-
ing and birthweight. All CpGs on the growth factor inde-
pendent 1 transcription repressor (GFI1) gene (eight
CpGs) and the neurogenin 1 (NEUROG1) gene
(two CpGs) showed mediation with P<0.07 in GECKO
(Table 3), whereas the other CpGs did not (Supplementary
Table S3, available as Supplementary data at IJE online).
None of these CpGs showed interaction with the exposure
or covariates in its effect on birthweight (Supplementary
Tables S4a–h, available as Supplementary data at IJE
online). We limited replication analysis to CpGs in GFI1
because it showed the most robust results.
Table 1. Characteristics of children exposed and unexposed
to maternal smoking (n¼ 255 in GECKO)
Characteristics Unexposed
(n¼126)
Exposed
(n¼129)
Pdifference
Male 66 (52.4) 70 (54.3) 0.76
Birthweight 36856 563 34046 464 <0.0001
Gestational age 39.86 1.2 39.76 1.3 0.18
Maternal age at childbirth 31.16 3.6 29.76 4.7 <0.01
Maternal low/middle
educational level
70 (55.6) 105 (81.4) <0.0001
Maternal pre-pregnancy BMI 23.96 3.3 24.96 5.1 0.09
Number of cigarettes smoked NA 10 (1–30)
Data shown as n (%) or mean6 SD. Except for number of cigarettes
smoked: median (range). P-values are given for independent samples t-test
(continuous) or chi-square test (categorical).
Unexposed group was defined as no smoking during pregnancy, by mother
or by father. Exposed group was defined as smoking during pregnancy by
mother.
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Replication and meta-analysis in ALSPAC and
Generation R confirmed the association with maternal
smoking for seven of the eight CpGs in GFI1 and medi-
ation was replicated for three of the eight GFI1 CpGs:
cg09935388, cg14179389 and cg12876356 (Table 4).
Although not all these CpGs were significant in the two
individual replication cohorts, directions of the effects
were consistent (Supplementary Table S5, available as
Supplementary data at IJE online). Joint meta-analysis of
discovery and replication cohorts combined showed that
differential methylation of these three GFI1 CpGs ex-
plained 12–19% of the 202 g lower birthweight in smoking
mothers. For example, this was 19% for cg09935388
calculated as follows: newborns of smoking mothers had a
202 g lower birthweight compared with unexposed new-
borns (meta-analysis of bc, data not shown). After adding
the CpG as mediator in the model, the effect of smoking
on birthweight decreased by 37.5 g (bc  bc’ in overall
meta-analysis, see Table 4). Therefore, 37.5/202¼ 19% of
the 202 g lower birthweight in exposed newborns could be
explained by mediation through differential methylation.
We observed 28 enriched GO terms (FDR< 0.05) for
the 110 genes in the interaction network (Table 5). Most
enriched terms are closely related and point towards regu-
lation of immune system processes, particularly the cell-
mediated immunity response.
Table 2. Top 35 CpGs with methylation difference between children exposed and unexposed to maternal smoking (FDR<0.05)
CpG Closest gene Chr Bp
position
Location
in gene
Located in island,
shore or open sea
Mean methylation
percentage
Methylation
difference
P-value
cg05575921 AHRR 5 373378 Body Shore 0.688 0.073 1.14E-25
cg04180046 MYO1G 7 45002736 Body Island 0.497 0.056 1.10E-14
cg09935388 GFI1 1 92947588 Body Island 0.661 0.105 2.67E-14
cg11429111 NEUROG1a 5 134813329  Open sea 0.690 0.048 7.17E-12
cg14179389 GFI1 1 92947961 Body Island 0.188 0.061 1.76E-11
cg12803068 MYO1G 7 45002919 Body Shore 0.759 0.077 1.79E-11
cg12876356 GFI1 1 92946825 Body Island 0.660 0.107 1.79E-11
cg01952185 NEUROG1a 5 134813213 – Open sea 0.590 0.047 3.32E-11
cg18146737 GFI1 1 92946700 Body Island 0.739 0.117 3.81E-11
cg22132788 MYO1G 7 45002486 Body Island 0.881 0.053 1.57E-10
cg23067299 AHRR 5 323907 Body Shore 0.723 0.038 2.66E-10
cg21611682 LRP5 11 68138269 Body Open sea 0.519 0.021 2.83E-10
cg18316974 GFI1 1 92947035 Body Island 0.784 0.102 3.27E-10
cg15507334 FRMD4A 10 14372913 TSS200 Open sea 0.556 0.028 2.90E-09
cg05549655 CYP1A1 15 75019143 TSS1500 Island 0.256 0.036 3.20E-09
cg19089201 MYO1G 7 45002287 3’UTR Island 0.796 0.037 3.53E-09
cg11924019 CYP1A1 15 75019283 TSS1500 Island 0.473 0.036 9.04E-09
cg09662411 GFI1 1 92946132 Body Island 0.714 0.066 9.55E-09
cg25949550 CNTNAP2 7 145814306 Body Shore 0.136 0.022 9.84E-09
cg22549041 CYP1A1 15 75019251 TSS1500 Island 0.304 0.052 1.53E-08
cg14817490 AHRR 5 392920 Body Open sea 0.336 0.030 3.98E-08
cg21161138 AHRR 5 399360 Body Open sea 0.742 0.024 6.18E-08
cg18092474 CYP1A1 15 75019302 TSS1500 Island 0.564 0.047 9.24E-08
cg22937882 AHRR 5 405774 Body Open sea 0.857 0.016 2.23E-07
cg25464840 FRMD4A 10 14372910 TSS200 Open sea 0.675 0.025 3.07E-07
cg24159436 PLCL2 3 16974681 1stExon Open sea 0.622 0.028 1.10E-06
cg04535902 GFI1 1 92947332 Body Island 0.797 0.057 1.77E-06
cg12101586 CYP1A1 15 75019203 TSS1500 Island 0.383 0.040 2.11E-06
cg11813497 FRMD4A 10 14372879 TSS200 Open sea 0.700 0.028 4.01E-06
cg01970407 AHRR 5 323320 Body Shore 0.678 0.023 4.07E-06
cg13834112 – 15 90361639 – Shelf 0.625 0.028 4.54E-06
cg23680900 CYP1A1 15 75017924 TSS200 Shore 0.149 0.015 5.01E-06
cg17292337 – 12 31272112 – Open sea 0.361 0.098 5.14E-06
cg01264106 LGALS1 22 38071602 TSS200 Shore 0.346 0.020 5.78E-06
cg10399789 GFI1 1 92945668 Body Shore 0.738 0.049 7.48E-06
Analyses were corrected for plate, sex, gestational age, maternal age, maternal education, maternal BMI and cell type composition.
Methylation difference was calculated from the average beta values of exposed minus unexposed groups.
aClosest gene was NEUROG1 (57 411–57 527 bp downstream), all other CpGs were mapped within the boundaries of the given genes.
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Discussion
We aimed to examine the effect of maternal tobacco smok-
ing during pregnancy on DNA methylation in cord blood.
Our second aim was to study the mediating effect of DNA
methylation in the association between maternal smoking
during pregnancy and offspring’s birthweight. We found
35 CpGs (FDR< 0.05) in 10 genes to be differentially
methylated in the exposed and non-exposed groups; 23 of
these CpGs (in eight genes) survived Bonferroni correction.
Furthermore, replication analysis confirmed methylation
of three GFI1 CpGs to mediate the association between
maternal smoking during pregnancy and decreased birth-
weight. Finally, functional network analysis showed that
the top differentially methylated genes influenced immune
system processes, particularly related to cell-mediated
immunity.
The association between smoking and methylation is
one of the most widely studied epigenetic associations and
evidence from EWASs on maternal tobacco smoking and
DNA methylation specifically in offspring is accumulating
rapidly.13–20 EWASs investigating the influence of cigarette
smoking have used a variety of DNA sources, including
placental cells,19 and studies in active smokers have been
performed in whole blood, peripheral blood,
lymphoblast DNA or lung alveolar macrophages10–12
with a generally high level of consistency across tissue and
studies. To our knowledge only a limited number of
EWASs have been published investigating the effect of
maternal smoking during pregnancy in offspring using the
450 K chip, of which only one was done in cord blood.17,18
The 23 differentially methylated CpGs mapped to eight
genes: AHRR, GFI1, MYO1G, CYP1A1, NEUROG1,
CNTNAP2, FRMD4A and LRP5. Differential methylation
of these genes (except for NEUROG1) was also observed
(but not all consistently replicated) in other EWASs in cord
and whole blood17,18 and/or in other studies into smoking
and methylation in adults.10,12,15 Previous studies related
methylation in the aryl-hydrocarbon receptor repressor
(AHRR) gene and the Cytochrome P450, family 1, sub-
family A1 (CYP1A1) gene to tobacco smoke exposure in
both smokers and newborns and most studies, including
ours, reported the same CpG as the top signal
(cg05575921).10,12,15,42,43 Both AHRR and CYP1A1 are
involved in the aryl-hydrocarbon receptor (AhR) pathway,
regulating the biological responses to hydrocarbons found
in cigarette smoke and xenobiotic metabolism in
general.43–45 The myosin-1 G (MYO1G) gene is involved
in haematopoietic processes and regulation of cell elasti-
city.46 The contactin-associated protein-like 2
(CNTNAP2) gene is involved in the development of the
nervous system47 and in neuropsychiatric disorders.
Finally, the low-density lipoprotein receptor-related pro-
tein 5 (LRP5) gene plays a role in skeletal homeostasis.48
Differential methylation of the FERM Domain Containing
4A (FRMD4A) gene has also previously been observed in
relation to tobacco smoke exposure in offspring of smok-
ing mothers (in whole blood).18 Interestingly, single nu-
cleotide polymorphisms in FRMD4A have been shown to
be involved in nicotine dependence.49
An important finding in our study was the mediating
effect of differential methylation of the growth factor inde-
pendent 1 transcription repressor (GFI1) gene in the asso-
ciation between maternal smoking and birthweight. GFI1
is known to play a role in developmental processes such
as haematopoiesis and oncogenesis.50,51 Thus, GFI1 could
be involved in cellular development and possibly fetal
growth. However, it has not previously been linked to
birthweight or other anthropometric measures.
Differential methylation of NEUROG1 also seemed to
mediate the association between maternal smoking and
birthweight in GECKO; however, our discovery results
in NEUROG1 await future replication. NEUROG1 is
known to be associated with neuronal differentiation and
neurogenesis,52 making a link to fetal development plaus-
ible. It should be noted that these CpGs were not mapped
within the NEUROG1 gene regions, but located close to
this gene (57 k downstream).
To the best of our knowledge, we were the first to inves-
tigate and identify statistical evidence of mediation by
DNA methylation (in GFI1) in the pathway from maternal
tobacco smoking during pregnancy to decreased birth-
weight of the offspring. Meta-analysis of all three cohorts
showed that three CpGs on GFI1 explained between 12%
and 19% of the effect of maternal smoking on birthweight.
These findings are promising, as this biological mechanism
seemed to explain part of the effect of smoking on birth-
weight. Other mechanisms causing reduced fetal growth
Figure 2. Volcano plot showing methylation differences between
exposed and unexposed against –log10 of the P-values.
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may involve impaired placental perfusion, chronically low
levels of fetal oxygen supply53 and sensitivity to adipocyto-
kines, e.g. leptin or ghrelin.54 However, it should be kept
in mind that many other factors are involved in intrauter-
ine growth and birthweight, e.g. malnutrition or stress,55,56
and that DNA methylation could not explain the total vari-
ation in birthweight resulting from smoking. As in any epi-
demiological study, residual confounding could not be
entirely excluded. However, maternal smoking during
pregnancy is known to have a direct adverse effect on
growth of the fetus and is therefore likely to have a much
stronger effect on methylation than other possible con-
founding factors.
We performed network and enrichment analysis to fa-
cilitate the functional interpretation of our 10 differentially
methylated genes. Most enriched GO terms were related to
immune system processes, especially to those related
to cell-mediated immunity. Thus, intrauterine exposure to
components in cigarette smoke seemed to elicit an immune
response in the offspring. Such an immune response in
smokers and offspring of smoking mothers may play a role
in the increased risk of developing asthma.57 This is in line
with studies showing that the AhR pathway activates the
immune system triggered by environmental exposures such
as tobacco smoke, pollutants and diet.58,59 Additional
research will be needed to show whether these smoking-
induced methylation effects may increase the risk of
developing autoimmune diseases.60–62 These results
seemed independent of cell type differences caused by ma-
ternal smoking, as we have adjusted all our analyses for
these differences, although we cannot entirely exclude that
cell correction was incomplete and residual cell (sub)type
effects could be possible.
The current study has many strengths. We found that
78% of our top CpG signals overlapped with those from a
previous EWAS on the same topic (data not shown), which
is a testament to the robustness of our findings.17
Moreover, cord blood is an excellent tissue to test for
methylation differences associated with maternal smoking,
because cord blood has not yet been exposed to external
influences other than those provided by the intrauterine en-
vironment. As such, potential confounding by those exter-
nal exposures on the newborn is minimized. Use of cord
blood to study DNA methylation as a potential mediator
of birthweight is less ideal, as it implicitly assumes that it
reflects methylation patterns from other tissues such as
muscle, fat and bone that might be more plausibly causally
related to fetal growth and birthweight. However, such
tissues would be prohibitively difficult to collect from new-
borns and for this reason cord blood is currently the most
commonly used tissue in epidemiological studies of new-
borns.63 Furthermore, in (epi)genetic epidemiology the
winner’s curse is a well-known phenomenon, which means
that the effect sizes of newly identified associations are
Table 3. Mediation analysis examining the indirect effect of maternal smoking during pregnancy on birthweight through methy-
lation in GECKO
bc SEc Pc R-square
BW5 smoking1 covariates 264.3 59.4 1.3E-05 0.307
BW5 smoking1CpG1 covariates bc’ bb SEb Pb Difference
in betas (bc - bc’)
Mediation
percentage
((bc - bc’) / bc)
Sobel
P-value
GFI1
cg09935388 143.3 1190.4 294.3 7.0E-05 121.0 g 45.8% 0.0003
cg14179389 214.4 820.7 427.0 5.6E-02 49.9 g 18.9% 0.064
cg12876356 158.0 970.4 253.4 1.6E-04 106.3 g 40.2% 0.001
cg18146737 165.6 856.3 227.7 2.1E-04 98.7 g 37.3% 0.001
cg18316974 177.7 841.3 248.7 8.0E-04 86.6 g 32.8% 0.002
cg09662411 196.5 1025.5 346.9 3.4E-03 67.8 g 25.7% 0.008
cg04535902 193.3 1222.9 324.1 2.0E-04 71.0 g 26.9% 0.002
cg10399789 217.3 1023.2 355.3 4.3E-03 47.0 g 17.8% 0.018
NEUROG1
cg11429111 202.2 1436.3 580.3 0.014 62.1 g 23.5% 0.019
cg01952185 219.4 1161.2 560.5 0.039 44.9 g 17.0% 0.052
BW, birthweight.
Covariates: plate, sex, gestational age, maternal age, maternal education, maternal BMI and cell type composition.
Sobel test¼ bc  bc’ / SE, where SE¼
pð b a2SEb2þ b b2  SEa2Þ.
The coefficients bc and bc’ can be interpreted as the amount of grams lower birthweight for smoking vs non-smoking mothers in the ‘smoking to birthweight’
and full model, respectively. bb represents the effect of methylation level (coded as a proportion between 0–1) on birthweight. For cg09935388 this means that an
increase of 100% in methylation level is associated with 1190.4 g higher birthweight. For extra information on the betas, see Figure 1.
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often overestimated in the discovery cohort. For this rea-
son we reported effect sizes of the combined analyses of
discovery and replication cohorts, which showed only par-
tial replication of our discovery findings. We were able to
replicate three of the eight mediating CpGs in two other
cohorts, which confirmed and strengthened our results.
However it should be kept in mind that not all CpGs repli-
cated and those CpGs that did replicate did not show such
strong mediation as in the discovery sample. Another
strength was the inclusion of the mediation analysis, giving
more insight into the biological pathway between maternal
smoking and birthweight.
To our knowledge, this is the first study to formally as-
sess and report this mediating effect of DNA methylation.
Additionally, we gave a functional interpretation of our re-
sults using functional network and enrichment analyses,
which indicated that the differentially methylated genes
play a role in activation of immune system processes.
Finally, we used the Houseman correction with the Reinius
dataset, a popular method to adjust for differences in cell
type distributions between the exposed and unexposed
groups of six cell types (B cells, granulocytes, monocytes,
NK cells, CD4þ T cells and CD8þ T cells).28,29 This,
reassuringly, showed no alterations in our top findings. The
top signals still survived Bonferroni correction after cell type
correction; however, the larger list of CpGs that survived
FDR differed substantially (Supplementary Table S2, avail-
able as Supplementary data at IJE online). Consequently,
the gene list that was used as input for the network and func-
tional enrichment analysis was also different. Interestingly,
the general pattern of results did not change, as we still
observed that most enriched terms pointed towards positive
regulation of particularly cell-mediated immune responses.
Furthermore, the mediation results did not change as we
observed significant mediation by the GFI1 gene and not by
any of the other genes, before and after cell type correction
Table 4. Results of meta-analysis (EWAS and mediation model) for GECKO, ALSPAC and Generation R
Epigenome-wide association study
Discovery Replication meta-analysis Overall meta-analysis (disc.1 repl.)
GECKO ALSPAC & Generation R GECKO, ALSPAC & Generation R
CpG Methylation
difference
P-value Methylation
difference
P-value Methylation
difference
P-value
cg09935388 0.105 2.67E-14 0.103 2.30E-19 0.104 4.61E-32
cg14179389 0.061 1.76E-11 0.064 2.54E-17 0.063 3.13E-27
cg12876356 0.107 1.79E-11 0.086 1.20E-14 0.093 2.48E-24
cg18146737 0.117 3.81E-11 0.098 1.24E-14 0.105 4.53E-24
cg18316974 0.102 3.27E-10 0.060 2.35E-07 0.074 4.00E-15
cg09662411 0.066 9.55E-09 0.049 8.52E-09 0.055 8.88E-16
cg04535902 0.057 1.77E-06 0.00925 3.15E-01 0.027 2.04E-04
cg10399789 0.049 7.48E-06 0.030 3.04E-03 0.039 1.75E-07
Mediation analysis
Discovery Replication meta-analysis Overall meta-analysis (disc.1 repl.)
GECKO ALSPAC & Generation R GECKO, ALSPAC & Generation R
CpG D beta
(bc - bc’)
Mediation %
((bc - bc’) / bc)
Sobel
P-value
D beta
(bc - bc’)
Mediation %
((bc - bc’) / bc)
Sobel
P-value
D beta
(bc - bc’)
Mediation
% ((bc - bc’) / bc)
Sobel
P-value
cg09935388 2121.0 g 45.8% 0.0003 228.7 g 16.2% 0.0081 237.5 g 18.6% 0.0003
cg14179389 249.9 g 18.9% 0.064 221.3 g 12.0% 0.0436 225.1 g 12.4% 0.0107
cg12876356 2106.3 g 40.2% 0.001 229.9 g 16.8% 0.0061 238.1 g 18.9% 0.0002
cg18146737 98.7 g 37.3% 0.001 19.6 g 11.0% 0.1143 31.3 g 15.5% 0.0062
cg18316974 86.6 g 32.8% 0.002 3.4 g 1.9% 0.7032 4.7 g 2.3% 0.5844
cg09662411 67.8 g 25.7% 0.008 8.5 g 4.8% 0.3730 15.7 g 7.8% 0.0788
cg04535902 71.0 g 26.9% 0.002 1.5 g 0.8% 0.8107 3.5 g 1.7% 0.5689
cg10399789 47.0 g 17.8% 0.018 4.5 g 2.5% 0.5237 9.4 g 4.7% 0.1611
Disc, discovery; repl, replication.
For all meta-analysis we have used a two-sided P< 0.05 as significance threshold.
Bold: CpG sites for which significant mediation was confirmed (P< 0.05 for both replication meta-analysis and overall meta-analysis).
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(mediation results before correction are not shown).
This method was based on a reference dataset of whole
blood samples from adult males, which have a different cell
composition from cord blood, and this cell type correction
did not account for more specific cell subtypes. However,
currently this is the best option because no cord blood refer-
ence dataset exists and, even in cord blood, this reference-
based cell type correction is the best method available as
recently applied by Kile and colleagues.27
In contrast to an earlier study, which observed dose-
dependency by maternal cotinine plasma levels,17 we did
not find an effect of the number of cigarettes smoked per
day. Joubert et al.17 found a dose-response relationship for
two of the significant genes, but not for all top genes. Thus,
a dose-response relationship could be expected for some
genes but not for all. Another potential reason for the lack
of a dose-response relationship in our data is our smaller
sample size compared with the study of Joubert et al.
A potential limitation was the use of self-reported
smoking behaviour during pregnancy. This may have
caused underreporting of smoking behaviour and possibly
could have resulted in an underestimation of the effects. In
the GECKO Drenthe cohort, 14% of the mothers smoked
during pregnancy. This is comparable to the prevalence of
7.6–13.2% found in The Netherlands in 2001–0764 and
12.3% in the USA.65 Furthermore, we observed results
that were highly comparable to the study by Joubert et al.
which measured smoking status objectively as plasma coti-
nine levels.17
We found support for our hypothesis that differential
methylation mediates part of the effect of smoking on
birthweight, but we could not be certain about the direc-
tion of causation in this observational study. One possibil-
ity is that methylation markers simply provided a better
measure of smoking exposure than the self-reported smok-
ing behaviour we used in our study. Such biomarkers
would then also be expected to be associated with birth-
weight. However, the fact that only GFI1 showed signifi-
cant association with birthweight and not, for example,
the AHRR cg05575921 CpG showing the strongest EWAS
Table 5. Enriched gene ontology terms identified in functional network analysis
GO ID Description FDR Occurrences
in sample
Occurrences
in genome
GO:0046649 Lymphocyte activation 1.87 e-07 16 294
GO:0042110 T cell activation 2.11E-07 14 217
GO:0042101 T cell receptor complex 3.07E-07 6 13
GO:0050900 Leukocyte migration 1.21e-06 13 214
GO:0050851 Antigen receptor-mediated signalling pathway 2.09e-06 10 108
GO:0002429 Immune response-activating cell surface receptor signalling pathway 2.98e-06 10 114
GO:0050852 T cell receptor signalling pathway 3.77E-06 9 86
GO:0002768 Immune response-regulating cell surface receptor signalling pathway 4.73e-06 10 123
GO:0002757 Immune response-activating signal transduction 9.00e-05 11 219
GO:0043235 Receptor complex 9.00e-05 9 128
GO:0002764 Immune response-regulating signalling pathway 1.29e-04 11 229
GO:0002253 Activation of immune response 4.75e-04 11 263
GO:0030098 Lymphocyte differentiation 5.31e-04 8 119
GO:0002696 Positive regulation of leukocyte activation 5.31e-04 9 164
GO:0030217 T cell differentiation 5.31E-04 7 82
GO:0050867 Positive regulation of cell activation 6.38e-04 9 170
GO:0002521 Leukocyte differentiation 1.66e-03 9 192
GO:0051249 Regulation of lymphocyte activation 2.02e-03 9 198
GO:0051251 Positive regulation of lymphocyte activation 2.60e-03 8 153
GO:0002274 Myeloid leukocyte activation 2.71e-03 6 70
GO:0002694 Regulation of leukocyte activation 4.27e-03 9 221
GO:0050865 Regulation of cell activation 7.94e-03 9 240
GO:0043230 Extracellular organelle 1.90e-02 5 61
GO:0070062 Extracellular vesicular exosome 1.90e-02 5 60
GO:0065010 Extracellular membrane-bounded organelle 1.90e-02 5 61
GO:0002250 Adaptive immune response 1.95e-02 6 103
GO:0001773 Myeloid dendritic cell activation 2.63e-02 3 12
GO:0050863 Regulation of T cell activation 2.63E-02 7 162
GO ID, gene ontology identification number.
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signal, contradicted this explanation. Another possibility
we could not entirely exclude is that retardation of fetal
growth expressed as lower birthweight led to differential
methylation rather than the other way around. However,
we believe this is unlikely given the primary role of epigen-
etic mechanisms in orchestrating changes in gene expres-
sion during growth and development.
We acknowledge that the Baron and Kenny approach for
mediation analysis has been criticized among others for its
dependency on and sensitivity to measurement errors, mis-
classification and violation of model assumptions.66,67
However, the Infinium HumanMethylation450 BeadChip is
a reliable instrument reflecting the state of the art in meas-
urement of genome-wide DNA methylation.68 Moreover,
mediation effects of three CpG sites were independently
replicated in cord blood data from two other birth cohorts,
in spite of presumably differential measurement errors be-
tween the three cohorts. Instability of methylation over time
is an additional potentially important source of measure-
ment error that could not be addressed by the cross-sec-
tional design of our study, which only looked at differential
methylation at birth. We backed up our mediation results
from the Baron and Kenny approach with a more advanced
statistical approach, and additionally applied causal medi-
ation analysis to the three replicated CpGs in the GECKO
cohort. This analysis uses a more general potential outcomes
framework, can provide additional distribution-free esti-
mates of the mediated effects and facilitates sensitivity ana-
lyses for the observed effects.67 Results of these analyses
were in line with our Baron-Kenny results and Sobel tests
(see Supplementary Note, available as Supplementary data
at IJE online).
Previously, fathers who started smoking early were
shown to have heavier sons,69 indicating a possible direct
effect of paternal smoking on fetal programming through
the sperm epigenome, which can affect embryogenesis.70,71
We did not explicitly test this possible direct effect in our
study. However, only 39 (30%) of the fathers in the
exposed group had smoked during pregnancy and, after
excluding these children from the analysis, 83% of our top
CpGs remained Bonferroni-significant. We also controlled
for this possible paternal smoking effect in the study de-
sign, as we only included in the unexposed group those
children whose mother and father did not smoke.
Our results suggested that in utero exposure to smoking
could have an effect on selected methylation markers
which may in turn affect later health outcomes in off-
spring. Our approach of testing the effects of intrauterine
exposures on DNA methylation in the child may serve as
a model that could be extended to other exposures.
One example is fetal exposure to polycyclic aromatic
hydrocarbons (PAHs), which has been linked to childhood
obesity.72 PAHs are produced during incomplete combus-
tion and are constituents not only of cigarette smoke but
also of many other sources. Results of such studies may
then provide guidance to future prevention efforts tailored
to limit certain exposures for pregnant women with major
potential impact on public health.
In conclusion, maternal tobacco smoking during preg-
nancy showed genome-wide methylation differences in 35
CpGs mapped to 10 genes measured in cord blood. Our
results showed remarkable similarity to previous findings,
confirming the robustness of the effects. Additionally, we
observed a potentially mediating role of DNA methylation
in the association between maternal smoking during preg-
nancy and birthweight of the offspring. We were able to
replicate the mediating effect for three CpGs in GFI1,
which confirmed and strengthened our findings. Finally,
our network and enrichment analyses indicated that smok-
ing in the mother may induce a cellular immune response
in the fetus.
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Supplementary data are available at IJE online.
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